Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Mio Hamatani, M.D., Ph.D.

Concepts (74)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Mio Hamatani's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Mio Hamatani has written about over time.
Autistic Disorder, 1 publications between 2016 and 2016, average publication date May 2016. Niemann-Pick Disease, Type C, 1 publications between 2016 and 2016, average publication date May 2016. Syndrome, 2 publications between 2016 and 2016, average publication date May 2016. Alanine-tRNA Ligase, 1 publications between 2016 and 2016, average publication date June 2016. Hereditary Central Nervous System Demyelinating Diseases, 1 publications between 2016 and 2016, average publication date June 2016. Heterozygote, 1 publications between 2016 and 2016, average publication date June 2016. Primary Ovarian Insufficiency, 1 publications between 2016 and 2016, average publication date June 2016. Phenotype, 2 publications between 2016 and 2023, average publication date February 2020. Axons, 1 publications between 2020 and 2020, average publication date April 2020. Leukoencephalopathies, 1 publications between 2020 and 2020, average publication date April 2020. Monocytes, 1 publications between 2020 and 2020, average publication date April 2020. Neuroglia, 1 publications between 2020 and 2020, average publication date April 2020. Multiple Sclerosis, 3 publications between 2017 and 2022, average publication date July 2020. Myasthenia Gravis, 1 publications between 2021 and 2021, average publication date January 2021. Multiple Sclerosis, Chronic Progressive, 1 publications between 2021 and 2021, average publication date April 2021. Multiple Sclerosis, Relapsing-Remitting, 1 publications between 2021 and 2021, average publication date April 2021. Disease Progression, 3 publications between 2020 and 2022, average publication date May 2021. Encephalomyelitis, Autoimmune, Experimental, 1 publications between 2022 and 2022, average publication date June 2022. Sulfoglycosphingolipids, 1 publications between 2022 and 2022, average publication date June 2022.

To see the data from this visualization as text, click here.
Hamatani's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (74)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.